Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Omega Diagnostics reports loss, still in dialogue with DHSC

Stock MarketsNov 25, 2021 09:19
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters

By Samuel Indyk

Investing.com – Omega Diagnostics (LON:ODX) announced an 81% increase in revenue in the first half of the year but swung to a loss as the gross margin increased.

In the six months to 30th September, Omega recorded revenue of £5.73 million, up from £3.16 million in the same period of 2020. The company said its gross margin fell to 34.4% from 42.9%, caused by increased direct labour in anticipation of COVID-19 contract work from the UK Department of Health and Social Care (DHSC).

The AIM-listed company reported a statutory loss for the period of £2.75 million versus a profit of £0.28 million last year.

DHSC Contract

Earlier this year, Omega reached an agreement with the DHSC whereby they would provide manufacturing capacity for up to 200 million COVID-19 later flow antigen tests. The company had been in discussions with the government but has yet to receive details of a test to manufacture.

Omega said that there is no test to manufacture under the DHSC contract, but they remain in dialogue for commercial use of equipment.

The company said it is now shifting in focus for COVID-19 test manufacture to support commercial market opportunities.

“We are confident that revenues in the second half will see significant growth in Health & Nutrition and for our CD4 product, and while COVID-19 revenues remain extremely difficult to predict they are expected to be more reliant on commercial partnerships than UK Government supply opportunities and are impacted by the timing of pending regulatory approvals being granted,” Omega Diagnostics Chairman Simon Douglas said. “Overall, we expect to see an improved sales performance across the Group for the full year and to see losses reduced in the second half.”

At 09:16GMT, shares in Omega Diagnostics were trading lower by 27.4% at 29.05 pence per share.

Omega Diagnostics reports loss, still in dialogue with DHSC
 

Related Articles

AJ Bell expects trading activity to stay normal
AJ Bell expects trading activity to stay normal By Reuters - Dec 02, 2021

(Reuters) -AJ Bell said on Thursday customer trading on its flagship platform would remain at normalised level after reporting higher annual earnings, helped by record customer...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email